.... It may also sell its antibiotics business at Ulverston, which produces brands such as Zinnat, Zinacef and Fortum. The moves, which also include outsourcing
some of the pharmaceutical manufacturing from GSK’s Worthing site in West Sussex and selling its MaxiNutrition brand, will lead to the loss of about 320 UK. ...
[Read full article on Guardian
Wednesday 19th of July 2017 02:51:53 PM